Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Corvus Pharmaceuticals (CRVS) Pension (2016 - 2018)

Corvus Pharmaceuticals' Pension history spans 4 years, with the latest figure at $3000.0 for Q2 2018.

  • Quarterly Pension fell 85.71% to $3000.0 in Q2 2018 from the year-ago period, while the trailing twelve-month figure was $3000.0 through Jun 2018, down 85.71% year-over-year, with the annual reading at $11000.0 for FY2017, 68.57% down from the prior year.
  • Pension came in at $3000.0 for Q2 2018, down from $7000.0 in the prior quarter.
  • In the past five years, Pension ranged from a high of $68000.0 in Q4 2015 to a low of $3000.0 in Q2 2018.
  • The 4-year median for Pension is $28000.0 (2017), against an average of $30909.1.
  • Year-over-year, Pension crashed 48.53% in 2016 and then plummeted 85.71% in 2018.
  • Corvus Pharmaceuticals' Pension stood at $68000.0 in 2015, then plummeted by 48.53% to $35000.0 in 2016, then plummeted by 68.57% to $11000.0 in 2017, then crashed by 72.73% to $3000.0 in 2018.
  • Per Business Quant, the three most recent readings for CRVS's Pension are $3000.0 (Q2 2018), $7000.0 (Q1 2018), and $11000.0 (Q4 2017).